glp-1 drugs sleep apnea Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Obstructive Syndrome Management: A Narrative Review Weight-loss drug approved to treat
Description
Neuronal and Intracellular Signaling Pathways Mediating GLP-1 Energy Balance and Glycemic Effects
2024;1(1) doi: 10.1038/s44355-024-00004-w
It is not entirely clear whether GLP-1RAs have direct effects on tumor cells, or if the benefits seen in animal models are entirely due to the indirect effect of decreased food intake
View methodology for full source list
Semaglutide 2.4 mg (Wegovy, Novo Nordisk), 2021
